Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
3.600
+0.100 (2.86%)
At close: Jan 17, 2025, 4:00 PM
3.610
+0.010 (0.28%)
After-hours: Jan 17, 2025, 5:03 PM EST
Amylyx Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$7.60
Upside
+111.11%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +233.33% | Dec 5, 2024 |
Baird | Baird | Hold → Buy Upgrades $3 → $11 | Hold → Buy | Upgrades | $3 → $11 | +205.56% | Nov 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +233.33% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +122.22% | Oct 18, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +11.11% | Jul 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +122.22% | Jul 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +122.22% | Jun 24, 2024 |
Mizuho | Mizuho | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | -16.67% | May 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +122.22% | May 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +122.22% | Apr 11, 2024 |
Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | -16.67% | Apr 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +122.22% | Apr 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $8 | Strong Buy | Maintains | $42 → $8 | +122.22% | Mar 12, 2024 |
Deutsche Bank | Deutsche Bank | Strong Buy Maintains $36 → $8 | Strong Buy | Maintains | $36 → $8 | +122.22% | Mar 11, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $40 → $4 | Strong Buy → Hold | Downgrades | $40 → $4 | +11.11% | Mar 11, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.